Transplantation for Patients with HIV
The Transplant Institute at BIDMC is one of 20 transplant centers in the United States - and the only center in New England - participating in a National Institutes of Health (NIH) sponsored clinical trial of kidney and liver transplantation in patients who test positive for the human immunodeficiency virus (HIV). HIV is responsible for acquired immunodeficiency syndrome or AIDS.
Until recently, these patients, who have a high risk for end-stage liver disease, typically were not considered for transplantation because of their poor long-term prognosis. However, new treatments, such as highly active antiretroviral therapy (HAART), have improved the outlook for HIV, and that, in turn, has opened the door for transplantation to more people who test positive for this virus.